Effectiveness of Homoeopathic Medicine in treating Inflammatory Bowel Disease

Phase 3

• Conditions: Health Condition 1: K50- Crohns disease [regional enteritis]Health Condition 2: K51- Ulcerative colitis

• Registration Number: CTRI/2022/03/040881
• Lead Sponsor: Anju KS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Diagnosed cases of IBD by GI endoscopy

Patient with signs and symptoms of IBD

Patients with elevated fecal calprotectin

Exclusion Criteria

Pregnant and lactating mother.

Patients who are diagnosed with immune deficiency diseases like AIDS, cancer, etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To find out the significant reduction in fecal calprotectin level in inflammatory bowel disease with homoeopathic constitutional medicine  <br/ ><br> <br/ ><br>Timepoint: 1 year <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
To find out symptomatic improvement of IBD patients with homoeopathic constitutional medicine using the IBD control questionnaire and IBD control VAS. <br/ ><br> <br/ ><br>To find out disease activity in IBD patients with homeopathic constitutional medicine using Manitoba IBD Index <br/ ><br> <br/ ><br>To find out changes in  the lower GI endoscopy in IBD patients with homoeopathic constitutional medicine <br/ ><br> <br/ ><br>To analyze recurrence and comorbidities in IBD patients with homoeopathic constitutional medicine. <br/ ><br> <br/ ><br>Timepoint: 1 year follow up